The strong share count increases by Schwab and UBS suggest underlying demand, but the drop in position value indicates LYEL's stock price declined during the quarter. Traders should assess whether the passive buying reflects index inclusion or rebalancing rather than fundamental optimism. Monitor next earnings report for catalysts that could resolve institutional divergence.
LYEL drugs
LYEL drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 2 $24.10entry
- T+1 · 9mo ago −3.19%α −2.28% · $23.33
- T+5 · 8mo ago +5.81%α +7.02% · $25.50
- T+20 · 8mo ago −19.96%α −12.02% · $19.29
- T+60 · 6mo ago −32.07%α −41.40% · $16.37
How similar events traded
Executive Summary
In Q4 2024, three mega-passive institutions, Wells Fargo, Schwab, and UBS, increased their positions in Lyell Immunopharma (LYEL), with UBS doubling its stake. This buying activity was partially offset by a significant trim from Morgan Stanley, which reduced its holdings by nearly 30%. The cluster shows divergent views among passive managers, but the largest net increase came from UBS, suggesting growing institutional interest despite overall negative net value change due to share price decline.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$1.2M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| UBS | DOUBLED | +695% | $553.0K | $403.0K |
| Schwab | ADD | +43.4% | $1.1M | -$530.1K |
| Wells Fargo | ADD | +27.8% | $60.0K | -$41.4K |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | TRIM | -29.7% | $2.4M | -$1.6M |
Key Facts
- UBS doubled its position in LYEL, increasing shares from 108.7K to 864.3K (+755.6K shares), with value rising by $403K.
- Schwab added 498.4K shares (+43.4%), though value dropped from $1.6M to $1.1M due to falling stock price.
- Wells Fargo increased shares by 20.5K (+27.8%), but position value fell $41,449.
- Morgan Stanley trimmed 513,621 shares (-29.7%), reducing position value by $1.6M.
- All institutions involved are classified as mega-passive, indicating index-driven or rules-based strategies rather than active conviction.
Financial Impact
Institutions accumulated $403K in net new value (after accounting for market moves), while one major holder reduced exposure by $1.6M. Total position value among tracked funds decreased due to share price decline despite share count growth.
Risk Factors
- All activity comes from passive managers, moves may reflect index rebalancing, not fundamental views.
- Net value of positions declined across buyers despite share accumulation, signaling possible downward price pressure on LYEL stock.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-LYEL-2024-Q4 |
Track record
21 reports on LYEL
5 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +17.99% at T+60 after the Jun 8, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 13, 20263d ago S-3 Neutral 3/10 Entry $14.30 settles Nov 17
- Nov 12, 20264d ago Insider Cluster Bullish 6/10 Entry $14.30 to $14.65 ▲ +2.45% +4.36% vs SPY
- Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $16.86 to $15.64 ▼ −7.24% −6.88% vs SPY
- Nov 5, 202611d ago Insider Cluster Bullish 7/10 Entry $14.86 to $15.42 ▲ +3.77% +1.40% vs SPY
- Nov 4, 202612d ago 8-K Neutral 4/10 No price data
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $15.00 to $14.86 ▼ −0.93% −1.25% vs SPY
- Nov 4, 202612d ago 8-K Bearish 5/10 Entry $15.43 to $15.00 ▲ +2.79% −1.62% vs SPY
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $15.43 to $15.00 ▼ −2.79% +1.62% vs SPY
- Aug 25, 202611w ago Insider Cluster Neutral 4/10 Entry $14.80 to $14.61 ▼ −1.28% −1.94% vs SPY
- Jul 22, 202616w ago EFFECT Neutral 4/10 Entry $12.84 to $12.78 ▼ −0.47% +0.77% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers